Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
about
IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinasesMicrowave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis.TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase.Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitisTPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control TH2-Mediated Immunopathology.Aberrant expression of COT is related to recurrence of papillary thyroid cancer.Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells.Tpl2 promotes innate cell recruitment and effector T cell differentiation to limit Citrobacter rodentium burden and dissemination.TPL-2 restricts Ccl24-dependent immunity to Heligmosomoides polygyrus.TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury.Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold.A TPL2 (MAP3K8) disease-risk polymorphism increases TPL2 expression thereby leading to increased pattern recognition receptor-initiated caspase-1 and caspase-8 activation, signalling and cytokine secretion.TPL2 mediates IL-17R signaling in neuroinflammation.Assaying kinase activity of the TPL-2/NF-κB1 p105/ABIN-2 complex using an optimal peptide substrate.A20-binding inhibitor of NF-κB (ABIN) 2 negatively regulates allergic airway inflammation
P2860
Q33767550-1D6CA86B-9DEA-4939-B44D-006A82307EE8Q34124465-39A16B59-A89F-45A3-AB1D-84ECCE620819Q34533855-7C5FE7CA-DAA7-4ECE-BB8E-1601A332F484Q35187958-6F07BE0C-DC65-43B4-AFD3-C6D9F68E9165Q36093909-E05A2711-B10E-45B4-A2B6-F504B0846B29Q36152396-2BF82E13-69AB-461A-B61D-9FC1287E3F05Q37626144-58AA5756-4DDB-45BA-83A9-6A75393218ADQ38650821-BB90D4DA-D699-46B2-8FB6-E31DA7E96F92Q38651585-71676FA3-0ED4-4F5A-A832-40E416FC01D9Q38780085-ADDF6504-6BEC-43D0-A0C0-ADCE2EFA90B3Q40645815-394E6F72-3EB1-47A6-B803-6E1906741A70Q41825901-EDA7ADAF-B17E-4C3D-B94C-1BBA0005BC95Q42741761-8B9EEC12-5C30-4A62-AD11-3A6D321C2C36Q43139032-B62DEFBF-51E5-46F0-8998-3A49F83410CDQ49920636-807D2ABC-73D9-48C8-89FC-CBFE0AD251B9Q58610859-07866AA8-795C-4B02-BE8C-9D2380D1BD3E
P2860
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@en
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@nl
type
label
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@en
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@nl
prefLabel
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@en
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@nl
P2093
P2860
P50
P356
P1476
Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
@en
P2093
Abduelhakem Ben-Addi
Christine Brender
Eva Gückel
Katrin Kierdorf
Marco Prinz
Niki Tsakiri
Philip N Tsichlis
Srividya Sriskantharajah
Steven C Ley
P2860
P304
P356
10.4049/JIMMUNOL.1300172
P407
P577
2014-03-17T00:00:00Z